Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TriCalm Hydrogel in Immunotherapy-Related Pruritus
NCT06748404Phase 2Recruiting
- Sponsor
- University of California, San Diego
- Start
- Mar 2025
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of TriCalm in pruritus, sponsored by University of California, San Diego. Started Mar 2025; status: recruiting.
02
Drugs
TriCalm
03
Conditions
pruritus
Beyond the preview
Go deeper on NCT06748404.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06748404.